The role of miR-765 in human cancers
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.112779 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Asma'a H Mohamed und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Engineering Department, College of Engineering and Technologies, Al-Mustaqbal University, Babil 51001, Hilla, Iraq. Electronic address: as…. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben.
Abstract (Originalsprache)
MicroRNAs, a collection of short noncoding RNAs, are promising biomarkers for identifying cancer in its early stages and tracking the effectiveness of treatment. This is due to their critical role in regulating gene expression and other vital biological functions via cell-level epigenetic mechanisms. This review brings together data on the molecular and clinical effects of miR-765 on different types of cancer. Significant variation in miR-765 levels has been observed in a variety of cancer types, suggesting that it could have an oncogene or tumor suppressor role. A number of pathways, including PLP2/Notch, VEGFA/Akt1, PDX1, KLK4, RUNX2, DPF3, EMP3, APE1, ERK/EMT axis, and others, are impacted by the inclusion of miR-765 in their analysis. MiR-765 is an essential biomarker that shows promise as a diagnostic tool for various types of cancer. The latest research has identified them as reliable predictive markers for detecting tumor development at an early stage. Based on our study, miR-765 shows promising potential as a biomarker for prognosis in multiple types of cancer. Specifically, we suggest that miR-765 could be an early detection marker for tumor development, progression, and metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Engineering Department, College of Engineering and Technologies, Al-Mustaqbal University, Babil 51001, Hilla, Iraq. Electronic address: asmaa_hassan@uomus.edu.iq.
- Department of Clinical Biochemistry, College of Medicine, King Khalid University, Abha, Saudi Arabia.
- Department of Pathology, College of Medicine, Qassim University, Buraidah, Saudi Arabia.
- Department of Public Health, College of Applied Medical Sciences, Khamis Mushait Campus, King Khalid University, Abha 62561, Saudi Arabia.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O.Box 11099, Taif 21944, Saudi Arabia.
- Department of Oral & Maxillofacial Surgery and Diagnostic Sciences, Faculty of Dentistry. Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Zitieren
APA
Mohamed, A. H., Patel, A. A., Abdulmonem, W. A., Muzammil, K., Shafie, A., Ashour, A. A., Mirdad, T. M. A., Mallick, A. K., Alsaiari, A. A., & Almalki, A. A. (2024). The role of miR-765 in human cancers. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112779
Vancouver
Mohamed AH, Patel AA, Abdulmonem WA, Muzammil K, Shafie A, Ashour AA, et al. The role of miR-765 in human cancers. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112779
BibTeX
@article{Mohamed2024,
author = {Mohamed, Asma'a H and Patel, Ayyub Ali and Abdulmonem, Waleed Al and Muzammil, Khursheed and Shafie, Alaa and Ashour, Amal Adnan and Mirdad, Tarek Mahmoud Abdul-Malik and Mallick, Ayaz Khurram and Alsaiari, Ahad Amer and Almalki, Abdulraheem Ali},
title = {The role of miR-765 in human cancers},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.112779}
}
EUVIMED